Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-10,505
Closed -$19.4K – 1372
2024
Q4
$19.4K Buy
+10,505
New +$23.2K ﹤0.01% 1361
2020
Q4
– Sell
-3,456
Closed -$7K – 1196
2020
Q3
$7K Sell
3,456
-1,578
-31% -$3.96K ﹤0.01% 1980
2020
Q2
$13K Buy
5,034
+707
+16% +$1.67K ﹤0.01% 1758
2020
Q1
$20K Hold
4,327
– – ﹤0.01% 2092
2019
Q4
$20K Buy
4,327
+2,021
+88% +$8.96K ﹤0.01% 2092
2019
Q3
$10K Sell
2,306
-1,557
-40% -$7.46K ﹤0.01% 2332
2019
Q2
$18K Buy
3,863
+1,036
+37% +$4.64K ﹤0.01% 2092
2019
Q1
$12K Sell
2,827
-388
-12% -$1.78K ﹤0.01% 2283
2018
Q4
$12K Buy
+3,215
New +$13.7K ﹤0.01% 2191
2018
Q3
– Sell
-3,025
Closed -$14K – 1425
2018
Q2
$14K Sell
3,025
-1,757
-37% -$10.3K ﹤0.01% 1796
2018
Q1
$30K Hold
4,782
– – ﹤0.01% 1806
2017
Q4
$30K Buy
4,782
+1,471
+44% +$9.41K ﹤0.01% 1806
2017
Q3
$21K Buy
3,311
+361
+12% +$2.24K ﹤0.01% 1938
2017
Q2
$16K Hold
2,950
– – ﹤0.01% 1985
2017
Q1
$16K Sell
2,950
-14,401
-83% -$79K ﹤0.01% 1985
2016
Q4
$84K Buy
17,351
+8,515
+96% +$46K ﹤0.01% 1446
2016
Q3
$53K Hold
8,836
– – ﹤0.01% 1592
2016
Q2
$52K Buy
8,836
+4,837
+121% +$26K ﹤0.01% 1561
2016
Q1
$19K Buy
3,999
+2,500
+167% +$11.5K ﹤0.01% 1837
2015
Q4
$6K Sell
1,499
-3,497
-70% -$17.1K ﹤0.01% 2201
2015
Q3
$24K Sell
4,996
-10,531
-68% -$57.2K ﹤0.01% 1831
2015
Q2
$94K Sell
15,527
-18,723
-55% -$116K ﹤0.01% 1434
2015
Q1
$197K Sell
34,250
-22,690
-40% -$141K ﹤0.01% 1253
2014
Q4
$353K Buy
56,940
+2,510
+5% +$15.9K ﹤0.01% 1098
2014
Q3
$355K Buy
54,430
+12,200
+29% +$85.9K ﹤0.01% 993
2014
Q2
$296K Hold
42,230
– – ﹤0.01% 1038
2014
Q1
$312K Buy
42,230
+11,430
+37% +$80K ﹤0.01% 1034
2013
Q4
$226K Buy
+30,800
New +$225K ﹤0.01% 1116

Other funds holding ABEV

Glenmede Trust's ABEV Position: Q1 2025 in Review

Glenmede Trust sold out of Ambev (ABEV) in Q1 2025, closing a stake of 10,505 shares — an estimated $19.4K sold.

Glenmede Trust first reported a position in ABEV in Q4 2013 and held it in 28 quarters. The position peaked at $355K in Q3 2014. 363 funds tracked by Wall St. Rank hold ABEV as of Q1 2025.

  • Glenmede Trust reported no remaining Ambev position as of Q1 2025 after selling out during the quarter.
  • Glenmede Trust sold 10,505 Ambev shares in Q1 2025, an estimated $19.4K.
  • Glenmede Trust first reported a position in Ambev in Q4 2013 and held it in 28 quarters.
  • Glenmede Trust's Ambev position peaked at $355K in Q3 2014.
  • 363 funds tracked by Wall St. Rank held Ambev as of Q1 2025.

Based on Glenmede Trust's 13F filing for Q1 2025, filed 15 May 2025.